Advertisement
Document › Details
Kadans Science Partner. (12/12/24). "Press Release: Kadans Science Partner with the Support of Accumulata to Transform Former Signa Property into Life Science Innovation Hub". Berlin.
Region | Berlin | |
Country | Germany | |
Organisation | Kadans Science Partner (NL) | |
Group | Axa (Group) | |
Organisation 2 | McDermott Will & Emery (MWE) (Group) | |
Product | business park management / science park management | |
Product 2 | real estate | |
Kadans Science Partner have acquired the strategic 9,037 sqm property at Franklinstraße 8, in Berlin’s vibrant Charlottenburg district. This acquisition marks Kadans’ first footprint in Berlin, one of the leading Life Science clusters in Germany and one of Germany’s most prominent hubs for innovation. The project, to be branded “Plus Ultra Berlin”, will become a state-of-the-art, multi-tenant lab and office complex with a unique riverside setting, expected to be delivered in Q2/2028.
Project overview
The Franklinstraße 8 site, situated along the banks of the Spree River, offers prime potential for Kadans’ signature approach to Life Science campuses, aligning with their commitment to fostering innovation and collaboration. Working with existing plans from Berlin-based architects Gewers Pudewill, Kadans will adapt and enhance the project to include approximately 30,000 sqm of lab and office space, optimized for sustainable development and high-tech infrastructure. Partnering with Munich-based Accumulata Group, Kadans aims to leverage Accumulata’s expertise as a service developer for project execution.
Kadans Science Partner was supported by the law firm McDermott Will & Emery and JLL during the acquisition. A5 Planung GmbH accompanied the DD process.
More information about the building, its location, and Kadans’ strategic vision for this project will be provided soon.
Record changed: 2024-12-19 |
Advertisement
More documents for Axa (Group)
- [1] Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz"....
- [2] BioInvent International AB. (7/12/22). "Press Release: BioInvent Has Successfully Carried Out a Directed Share Issue of approximately SEK 300 Million (approximately USD 28.3 Million) [ Not for US, AU, et al. ]". Lund....
- [3] AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments"....
- [4] Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London"....
- [5] AXA Investment Managers. (7/26/21). "Press Release: AXA IM Alts Raises €1.9 Billion for European Life Sciences Investments"....
- [6] AXA Investment Managers. (11/26/20). "Press Release: AXA Investment Managers - Real Assets to Enter European Life Science Sector with Acquisition of Kadans Science Partner Platform"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top